EIP
ABBV icon

Easterly Investment Partners’s AbbVie ABBV Stock Holding History

Easterly Investment Partners’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-6,154
Closed -$1.09M – 187
2024
Q4 		$1.09M Sell
6,154
-11
-0.2% -$2.02K 0.09% 143
2024
Q3 		$1.22M Sell
6,165
-7
-0.1% -$1.31K 0.1% 150
2024
Q2 		$1.06M Sell
6,172
-3,868
-39% -$641K 0.09% 143
2024
Q1 		$1.83M Sell
10,040
-10,363
-51% -$1.79M 0.14% 127
2023
Q4 		$3.16M Sell
20,403
-4,051
-17% -$591K 0.34% 81
2023
Q3 		$3.65M Buy
24,454
+6,210
+34% +$912K 0.4% 78
2023
Q2 		$2.46M Buy
18,244
+4,009
+28% +$588K 0.22% 102
2023
Q1 		$2.27M Buy
14,235
+1,311
+10% +$200K 0.2% 103
2022
Q4 		$2.09M Buy
12,924
+5,012
+63% +$769K 0.18% 104
2022
Q3 		$1.06M Buy
7,912
+421
+6% +$60.4K 0.1% 130
2022
Q2 		$1.15M Sell
7,491
-5,376
-42% -$821K 0.1% 129
2022
Q1 		$2.09M Sell
12,867
-99,783
-89% -$14.5M 0.16% 105
2021
Q4 		$15.3M Sell
112,650
-149,642
-57% -$17.7M 1.11% 32
2021
Q3 		$28.3M Buy
262,292
+23,394
+10% +$2.67M 1.92% 11
2021
Q2 		$26.9M Sell
238,898
-4,979
-2% -$561K 3.16% 12
2021
Q1 		$26.4M Sell
243,877
-39,291
-14% -$4.2M 3.16% 9
2020
Q4 		$30.3M Sell
283,168
-1,405,893
-83% -$135M 4.2% 5
2020
Q3 		$148M Buy
1,689,061
+355,428
+27% +$33.5M 5.87% 2
2020
Q2 		$131M Sell
1,333,633
-655,850
-33% -$57.7M 5.95% 1
2020
Q1 		$152M Buy
1,989,483
+56,255
+3% +$4.79M 6.72% 1
2019
Q4 		$171M Sell
1,933,228
-723,827
-27% -$60.1M 4.81% 3
2019
Q3 		$201M Buy
2,657,055
+1,452,264
+121% +$99.6M 5.65% 2
2019
Q2 		$87.6M Buy
+1,204,791
New +$94.7M 2.2% 22

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Easterly Investment Partners's ABBV Position: Q1 2025 in Review

Easterly Investment Partners sold out of AbbVie (ABBV) in Q1 2025, closing a stake of 6,154 shares — an estimated $1.09M sold.

Easterly Investment Partners first reported a position in ABBV in Q2 2019 and held it in 23 quarters. The position peaked at $201M in Q3 2019. 3,819 funds tracked by Wall St. Rank hold ABBV as of Q1 2025.

  • Easterly Investment Partners reported no remaining AbbVie position as of Q1 2025 after selling out during the quarter.
  • Easterly Investment Partners sold 6,154 AbbVie shares in Q1 2025, an estimated $1.09M.
  • Easterly Investment Partners first reported a position in AbbVie in Q2 2019 and held it in 23 quarters.
  • Easterly Investment Partners's AbbVie position peaked at $201M in Q3 2019.
  • 3,819 funds tracked by Wall St. Rank held AbbVie as of Q1 2025.

Based on Easterly Investment Partners's 13F filing for Q1 2025, filed 2 May 2025.